Pharma policy GoM to decide on price control

Tuesday's meeting to examine the pricing policy prepared by ministry of chemicals & fertilisers

Image
Joe C Mathew New Delhi
Last Updated : Jan 20 2013 | 3:11 AM IST

On Tuesday, a group of ministers (GoM) led by agriculture minister Sharad Pawar will examine the proposed National Pharmaceutical Pricing Policy (NPPP) prepared by the ministry of chemicals and fertilisers.

The key issue is to vet the various price control mechanisms suggested by the ministry and other stakeholders. The group will decide whether the policy should be market-based or a system of exact cost plus profit for medicine price fixing. The extent of price control, whether restricted to the specific strengths of drugs mentioned in the National List of Essential Medicines (NLEM) or on all strengths and combinations of NLEM, will be decided.

The meeting is the first sitting of the GoM constituted for the purpose in September 2009. Intense efforts by industry and civil society interest groups to tweak the policy in their favour may now continue at the GoM level. Industry stakeholders said Pawar would meet drug trade representatives to hear their views ahead of the meeting.

NPPP 2011, the basic drug price control plan formulated by the ministry of chemicals and fertilisers, was uploaded on the ministry website for stakeholder views several months earlier. Of over two dozen suggestions, the ministry is to indicate its preferences at the GoM. The latter’s decision will then require Cabinet approval and a final nod of the Supreme Court before the policy can be put in force.

NPPP had suggested a price cap for essential drugs on the basis of the average price of top-selling brands. While industry was not averse, civil society groups had been demanding the average of lowest priced drugs as the ceiling. The authorities may now look for a middle path.

Ghulam Nabi Azad, minister of health and family welfare; Kapil Sibal, minister of human resource development and communications & information technology; Anand Sharma, minister of commerce and industry; M K Alagiri, minister of chemicals and fertilisers; Salman Khurshid, minister of law and justice and Montek Singh Ahluwalia, deputy chairman, Planning Commission, are the other GoM members.

The previous GoM on pharma, set up in January 2007, was also headed by Pawar. It held four meetings through 2007 and 2008 but could not make any recommendations. The last meeting was in April 2008. Although the next meeting of the GoM was expected to finalise the policy, it never happened.

The delay in the announcement of a policy had led public interest groups petitioning the Supreme Court. Preparation of NPPP and the proposed GoM meeting are fallouts of the judicial intervention.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 26 2012 | 12:52 AM IST

Next Story